Inflammatory response patterns in ICSI patients: A comparative study between chronic anovulating and normally ovulating women

Reproductive Sciences

Volumn 19, Issue 7, 2012, Pages 704-711

  Lamaita, Rívia Mara ^a,c   Pontes, Anaglória ^a   Belo, Andrezza V ^b   Caetano, João Pedro J ^c   Andrade, Sílvia P ^b   Cãndido, Eduardo Batista ^b   Traiman, Paulo ^a   Carneiro, Márcia Mendonça ^b   Silva Filho, Agnaldo L ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Hospital Mater Dei   (Brazil)

Author keywords

chronic anovulation; CRP; infertility; inflammatory response; intracytoplasmic sperm injection (ICSI); myeloperoxidase; N acetylglucosaminidase

Indexed keywords

ACETYLGLUCOSAMINIDASE; C REACTIVE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE;

ADULT; CHRONIC ANOVULATION; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; HUMAN; INFLAMMATION; INTRACYTOPLASMIC SPERM INJECTION; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; OVULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

ADULT; ANOVULATION; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLICULAR FLUID; HUMANS; INFERTILITY, FEMALE; MACROPHAGE ACTIVATION; NEUTROPHIL ACTIVATION; PROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; YOUNG ADULT;

EID: 84863511109     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111428518     Document Type: Review

References (48)

1. Abdulmalik U, Bako SM, William A.. Atiomo. Polycystic ovary syndrome: An overview. Rev Gynaecol Pract. 2005 ; 5 (2). 7
2. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update. 2008 ; 14 (4). 367-378
3. Matalliotakis I, Kourtis A, Koukoura O, Panidis D. Polycystic ovary syndrome: etiology and pathogenesis. Arch Gynecol Obstet. 2006 ; 274 (4). 187-197
4. Brannstrom M, Pascoe V, Norman RJ, McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril. 1994 ; 61 (3). 488-495
5. Brannstrom M, Norman RJ. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod. 1993 ; 8 (10). 1762-1775
6. Brannstrom M, Enskog A. Leukocyte networks and ovulation. J Reprod Immunol. 2002 ; 57 (1-2). 47-60
7. Wu R, Van der Hoek KH, Ryan NK, Norman RJ, Robker RL. Macrophage contributions to ovarian function. Hum Reprod Update. 2004 ; 10 (2). 119-133
8. Oakley OR, Kim H, El-Amouri I, et al. Periovulatory leukocyte infiltration in the rat ovary. Endocrinology. 2010 ; 151 (9). 4551-4559
9. Van Rensburg CE, Van Staden AM, Anderson R, Van Rensburg EJ. Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes. Mutat Res. 1992 ; 265 (2). 255-261
10. Belo AV, Barcelos LS, Ferreira MA, Teixeira MM, Andrade SP. Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice. Life Sci. 2004 ; 74 (23). 2827-2837
11. Dahm-Kahler P, Lofman C, Fujii R, Axelsson M, Janson PO, Brannstrom M. An intravital microscopy method permitting continuous long-term observations of ovulation in vivo in the rabbit. Hum Reprod. 2006 ; 21 (3). 624-631
12. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001 ; 86 (6). 2453-2455
13. Wunder DM, Kretschmer R, Bersinger NA. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum Reprod. 2005 ; 20 (5). 1266-1271
14. Sharma A, Atiomo W. Recent developments in polycystic ovary syndrome. Cur Obstet Gynaecol. 2003 ; 13: 281-286
15. Orvieto R, Chen R, Ashkenazi J, Ben-Haroush A, Bar J, Fisch B. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle. Hum Reprod. 2004 ; 19 (2). 357-359
16. Kousta E, Tolis G, Franks S.. Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences. Hormones (Athens). 2005 ; 4 (3). 133-147
17. Dhindsa G, Bhatia R, Dhindsa M, Bhatia V. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med. 2004 ; 50 (2). 140-144
18. Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011 ; 335 (1). 30-41
19. Escobar-Morreale HF, Luque-Ramirez M. Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome. Fertil Steril. 2011 ; 95 (5). 1730 e1731-1735
20. Benson S, Janssen OE, Hahn S, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008 ; 22 (2). 177-184
21. Cardozo E, Pavone ME, Hirshfeld-Cytron JE. Metabolic syndrome and oocyte quality. Trends Endocrinol Metab. 2011 ; 22 (3). 103-109
22. Schweigert FJ, Gericke B, Wolfram W, Kaisers U, Dudenhausen JW. Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. Hum Reprod. 2006 ; 21 (11). 2960-2968
23. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 ; 19 (1). 41-47
24. Cibula D. Is insulin resistance an essential component of PCOS?: the influence of confounding factors. Hum Reprod. 2004 ; 19 (4). 757-759
25. Workshop EC. Infertility revisited: the state of the art today and tomorrow. The ESHRE capri workshop. European Society for Human Reproduction and Embryology. Hum Reprod.. 1996 ; 11 (8). 1779-1807
26. Infertility revisited: the state of the art today and tomorrow. The ESHRE capri workshop. European Society for Human Reproduction and Embryology. Hum Reprod. 1996 ; 11 (8). 1779-1807
27. Tesarik J, Sousa M.. Key elements of a highly efficient intracytoplasmic sperm injection technique: Ca2+ fluxes and oocyte cytoplasmic dislocation. Fertil Steril. 1995 ; 64 (4). 770-776
28. Baley P. Sponge implants as models. Methods in Enzymology. 1988 ; 162: 327-334
29. Attaran M, Pasqualotto E, Falcone T, et al. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med. 2000 ; 45 (5). 314-320
30. Ferreira MA, Barcelos LS, Campos PP, Vasconcelos AC, Teixeira MM, Andrade SP. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). Br J Pharmacol. 2004 ; 141 (7). 1185-1192
31. Fogle RH, Hayes E, Santanam N, Shanti A, Parthasarathy S, Murphy A. Myeloperoxidase production by cumulus cells in women undergoing IVF. Fertil Steril. 2003 ; 80 (suppl 3). 252
32. Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol. 2009 ; 7: 40
33. Bukulmez O, Arici A. Leukocytes in ovarian function. Hum Reprod Update. 2000 ; 6 (1). 1-15
34. Smith MP, Flannery GR, Randle BJ, Jenkins JM, Holmes CH. Leukocyte origin and profile in follicular aspirates at oocyte retrieval. Hum Reprod. 2005 ; 20 (12). 3526-3531
35. Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod. 1994 ; 50 (2). 233-238
36. Arici A, Oral E, Bahtiyar O, Engin O, Seli E, Jones EE. Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells. Hum Reprod. 1997 ; 12 (6). 1233-1239
37. Kawano Y, Kawasaki F, Nakamura S, Matsui N, Narahara H, Miyakawa I. The production and clinical evaluation of macrophage colony-stimulating factor and macrophage chemoattractant protein-1 in human follicular fluids. Am J Reprod Immunol. 2001 ; 45 (1). 1-5
38. Dahm-Kahler P, Ghahremani M, Lind AK, Sundfeldt K, Brannstrom M. Monocyte chemotactic protein-1 (MCP-1), its receptor, and macrophages in the perifollicular stroma during the human ovulatory process. Fertil Steril. 2009 ; 91 (1). 231-239
39. Jasper M, Norman RJ. Immunoactive interleukin-1 beta and tumour necrosis factor-alpha in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries. Hum Reprod. 1995 ; 10 (6). 1352-1354
40. Wu R, Fujii S, Ryan NK, et al. Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome. Hum Reprod. 2007 ; 22 (2). 527-535
41. Glintborg D, Andersen M, Richelsen B, Bruun JM. Plasma monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome and associated with adiposity, but unaffected by pioglitazone treatment. Clin Endocrinol (Oxf). 2009 ; 71 (5). 652-658
42. Kjotrod SB, Romundstad P, von During V, Sunde A, Carlsen SM. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome. Fertil Steril. 2008 ; 89 (3). 635-641
43. Levin I, Gamzu R, Pauzner D, et al. Elevated levels of CRP in ovarian hyperstimulation syndrome: an unrecognised potential hazard?. BJOG. 2005 ; 112 (7). 952-955
44. Nowicka MA, Fritz-Rdzanek A, Grzybowski W, Walecka I, Niemiec KT, Jakimiuk AJ. C-reactive protein as the indicator of severity in ovarian hyperstimulation syndrome. Gynecol Endocrinol. 2010 ; 26 (6). 399-403
45. Amato G, Conte M, Mazziotti G, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. 2003 ; 101 (6). 1177-1182
46. Kwan I, Bhattacharya S, McNeil A, van Rumste MM. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev. 2008 ; (2). CD005289
47. Giles J, Requena A, Garcia-Velasco JA, Pacheco A, Pellicer J, Pellicer A. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study. Fertil Steril. 2008 ; 91 (4 suppl). 1366-1369
48. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002 ; 347 (20). 1557-1565